"To drive the prevention and cure of melanoma"
- To gain a better understanding of the immune system
- To better understand how treatments work through the immune system
- The development and effective use of less-toxic melanoma treatments
- To further investigate 'timing' the administration of melanoma treatments to work in harmony with an individual’s immune system
- The development of more-effective melanoma vaccines
- To reduce the cost of treatments
- Translation of our research to enable treatment of other types of cancer
Evidence is emerging worldwide that patients undergoing chemotherapy might realistically be treated, just as effectively, with less-toxic doses that can still be effective without producing the pain and suffering from side-effects that we currently see in people undergoing higher-dose chemotherapy. Current statistics show that only a little more than 10 percent of people treated with chemotherapy obtain any benefit from their therapy and less than two percent are ‘cured’ by the treatment. Some people may achieve temporary remission. In many cases, the chemotherapy agents appear to ‘damage’ the immune system. The stark fact is - we have to find a better way of giving treatments that assist the immune system. Even some of the newer therapies may be made more effective in this way.
There is ample evidence to show that vaccine treatment is effective and produces far fewer (or no) side-effects and less patient suffering. There are promising lines of research into melanoma vaccines that we wish to focus on.
We all know that there is a constantly increasing demand for funding in our healthcare system with major cost problems already occurring. Our mission is to seek to reduce the cost of treatments, for example, through our research into the more effective timing of chemotherapy and vaccine treatments. We reason that some of the therapies and principles could also be useful for improving treatments of other types of cancer, not just melanoma.
Cancer treatment in the future
...... and maybe the very near future, might look something like this:
A low-toxic vaccine and/or oral tablet that is administered in the home setting under the direction of a doctor, according to the appropriate time ‘window’ calculated from a patient’s own individual immune cycle, which produces a reduction in the growth of the cancer and improves or prolong the patient’s survival time.